Abstract
ABSTRACT:That non-rheumatic atrial fibrillation is an independent risk factor for cerebral infarction has not been established with certainty. The rationale underlying contemporary clinical trials of warfarin therapy for the prevention of stroke in patients who have non-rheumatic atrial fibrillation is that the majority of strokes in such patients are due to cardiogenic cerebral embolism. However, there is evidence to suggest that the increased probability of stroke attributed to this arrhythmia is due to its association with other risk factors such as hypertension, diabetes mellitus, and atherosclerosis. The question of who should be anticoagulated is a major public health issue since atrial fibrillation is present in approximately ten per cent of the general population aged 65 or more years.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Neurology,Neurology,General Medicine
Reference67 articles.
1. Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
2. Stroke prevention in atrial fibrillation study: carotid stenosis study group. Carotid stenosis in atrial fibrillation;Tegeler;Neurology,1989
3. Stroke prevention in atrial fibrillation study: progress report of an ongoing cooperative study;Feinberg;Neurology,1989
4. ATRIAL FIBRILLATION AND ANTITHROMBOTIC PROPHYLAXIS: A PROSPECTIVE META-ANALYSIS
5. Hemorrhagic Complications of Long-term Anticoagulant Therapy
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献